The COVID-19 pandemic has sparked digital transformation across the pharmaceutical industry, this pandemic has led to a major damage to the global economy, and this major crises has left a lot of industries re-examine the strength of legacy models in times of major trouble. Foreseeable, the most affected industry has been the global healthcare industry, as the world raced to test and treat people and also develop cure to stop the spread of the virus. Albeit, testing, treatments and vaccination programs that were brought up by government and some private firms have been in a way successful in developed countries, but existing obstacles in pharmaceutical research and development have heightened delays according to a number of experts in that field.

It is widely known that the clinical trial industry, as always been an important sector that has been handed the sole responsibility to test the safety and efficacy of newly created vaccines and therapeutics before they are introduced to thace world and that very important sector is been held back by various obstacles. The pandemic has demonstrated the need for fast and accurate solutions to tackle these obstacles and this will help ensure an efficient influx of new and viable medicines to the world market at large.

Today i will be taking you through a platform that that has taken note of the inefficiencies facing the global health industries and the have come up with revolutionary ideas.

https://www.triall.io/

TRIALL

Triall is creating a viable platform for tomorrow’s digital playing field in medical research and clinical trials. The brains behind this project is developing an infrastructure of blockchain-integrated microservices, facilitating a safe and efficient data exchanges between medical research professionals and their many desolated software systems. Steadily, the platform will be the world’s first online, multi-sided platform for clinical trials.

Taking advantage of both the increased digitalization of healthcare and the technological improvement in the blockchain and crypto space, Triall is making use of blockchain-based technologies to a sector that has become increasingly complex, data-heavy and fragmented over the past years

The mission of this revolutionary platform is to make sure that a future that is smart, safer and more-efficient clinical trials are done, where workflows are coherent and research data integrity is surely the outcome. The have taken an encompassing holistic approach which is majorly focused on consolidating the unassociated and authenticating clinical research data globally.

Triall Ecosystem key stakeholder and Areas they Intend to Cover

The Triall Ecosystem is intended to meet the demands of all important stakeholders in clinical trials. We’ve classified them into the following categories :

• Researchers: The whole party involved in clinical trial execution and management, including sponsor representatives and contract research company personnel which includes project managers, clinical research associates, monitors, and data managers, Site personnel which includes investigators, research nurses, and pharmacists,not also excluding any parties that do wish to use the Triall Ecosystem’s apps.
• Providers: Credible companies that offer software solutions for clinical trial operations. They may utilize blockchain-enabled data logging and authentication features, as well as other microservices, by connecting to the Triall Ecosystem, and also can offer their solutions in our multi-sided digital marketplace.
• Patients: These includes people who take part in clinical trials as research subjects which can either be patients or healthy volunteers. They may be linked to the Triall ecosystem via our patient-level eHealth applications, which seek to purposefully inform, recruit, engage, and empower this critical stakeholder group across clinical trial lifecycles.
• Contributors: These can be Individuals and organizations that provide technical services to the ecosystem and its community. They create, run, and audit smart contracts, as well as specifications, apps, and APIs for systems and their users. Other stakeholders benefit from the added functionality provided by these smart contracts, APIs, and apps.
• Maintainers: They include companies or persons who supply the underlying infrastructure on which the Triall Ecosystem runs, such as node operators and (cloud) storage providers. For example, Factom’s independent Authority Node Operators guarantee network integrity by validating data blocks and publishing to a blockchain ledger. They give the network strength, speed, and security by following a shared governance structure, being totally decentralized, and operating full nodes with rigorous hardware requirements.
• Triall Foundation: The Triall Foundation is a non-profit organization that is authorized by the Triall Community to administer the ecosystem. The foundation is a public service provider that operates on behalf of the community and is in charge of the Triall Ecosystem’s daily operations, management, development, and upkeep.
• Triall Community: The Triall Community is made up of all organizations and individuals who d wish to help the Triall Ecosystem grow and evolve, for example, by participating in decision-making, panels, discussions, development, or outreach. Community members can be members of the aforementioned stakeholder groups, but any party or individual with a genuine interest in the ecosystem is welcome.

INITIAL TOKEN OFFERING

• The total TRL token supply at ITO will be 175 million.
• A total of 91 million TRL (52%) will be distributed to the community, of which 31,5 million (18%) will be allocated to the Pre-sale, 42 million (24%) to the Treasury, and 17,5 million (10%) to the Triall Community Fund.
• Any unsold tokens from the Pre-sale will be burned.
• The Pre-sale price of 1 TRL will be $ 0,125 in the Private Pre-sale round (5%), $ 0,20 in the Retail Pre-sale round (2,5%), and $ 0,20* in the Late Bird Pre-sale round (7,5%). *
• The listing price of 1 TRL will be $ 0,25.
• The hard cap will be $ 1.093.750 in the Private Pre-sale round, $ 875.000 in the Retail Pre-sale round, and $ 2.625.000** in the Late Bird Pre-sale round.

CONCLUSIVELY; Triall creates a viable clinical trials platform with a unique long-term concept. Their Platform offers a variety of conveniences and is rich in features and benefits in one platform. The developers of this project believes that a state-of-the-art Information technology and scientific insights make unimaginable difference. And they strongly believe in advancing clinical development, consolidating the unconnected, and fostering a global ecosystem that promotes trust and reliability throughout all phases of clinical development in the world at large. This is interesting and they have the experience needed to achieve this beauty. Please go through the roadmap and see howlong they have come and how they intend to achieve this.

Please find the roadmap below;

ROADMAP

TEAM

FOR FURTHER INFORMATION PLEASE VISIT THE LINKS I HAVE PROVIDED BELOW;

Website: https://www.triall.io/

Twitter: https://twitter.com/triallofficial

Telegram community: https://t.me/triallcommunity

Telegram announcement channel: https://t.me/triallofficial

Medium: https://medium.com/triall-foundation

Author: Brainerdpaul

A sponsored article written for a bounty reward.”